The FMTs from patients with IBD/D+ or IBD/D− all caused colitis in mice: they significantly induced colon shortening; upregulated myeloperoxidase activity, IL-1β and IL-6 expression and increased the NF-κB+/CD11c+ cell population in the colon (Fig. 1a–g). Here, IL1B is linked to colitis.